| Zinc finger proteins in cancer progression J Jen, YC Wang Journal of biomedical science 23, 1-9, 2016 | 332 | 2016 |
| Alteration of DNA methyltransferases contributes to 5′ CpG methylation and poor prognosis in lung cancer RK Lin, HS Hsu, JW Chang, CY Chen, JT Chen, YC Wang Lung cancer 55 (2), 205-213, 2007 | 322 | 2007 |
| The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients RK Lin, YS Hsieh, P Lin, HS Hsu, CY Chen, YA Tang, CF Lee, YC Wang The Journal of clinical investigation 120 (2), 521-532, 2010 | 241 | 2010 |
| Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples YC Wang, YP Lu, RC Tseng, RK Lin, JW Chang, JT Chen, CM Shih, ... The Journal of clinical investigation 111 (6), 887-895, 2003 | 221 | 2003 |
| p53 Codon 72 Polymorphism in Taiwanese Lung Cancer Patients: Association with Lung Cancer Susceptibility and Prognosis YC Wang, CY Chen, SK Chen, YY Chang, P Lin Clinical Cancer Research 5 (1), 129-134, 1999 | 217 | 1999 |
| Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma HS Hsu, TP Chen, CH Hung, CK Wen, RK Lin, HC Lee, YC Wang Cancer 110 (9), 2019-2026, 2007 | 214 | 2007 |
| Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer RK Lin, CY Wu, JW Chang, LJ Juan, HS Hsu, CY Chen, YY Lu, YA Tang, ... Cancer research 70 (14), 5807-5817, 2010 | 212 | 2010 |
| Ethnic differences and functional analysis of MET mutations in lung cancer S Krishnaswamy, R Kanteti, JS Duke-Cohan, S Loganathan, W Liu, ... Clinical Cancer Research 15 (18), 5714-5723, 2009 | 212 | 2009 |
| Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression J Jen, YA Tang, YH Lu, CC Lin, WW Lai, YC Wang Molecular cancer 16, 1-12, 2017 | 201 | 2017 |
| Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts YC Wang, VM Maher, DL Mitchell, JJ McCormick Molecular and cellular biology 13 (7), 4276-4283, 1993 | 189 | 1993 |
| Rab-mediated vesicle trafficking in cancer HT Tzeng, YC Wang Journal of biomedical science 23, 1-7, 2016 | 165 | 2016 |
| SLIT2 attenuation during lung cancer progression deregulates β-catenin and E-cadherin and associates with poor prognosis RC Tseng, SH Lee, HS Hsu, BH Chen, WC Tsai, C Tzao, YC Wang Cancer research 70 (2), 543-551, 2010 | 163 | 2010 |
| Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non–small cell lung cancer MN Lee, RC Tseng, HS Hsu, JY Chen, C Tzao, WL Ho, YC Wang Clinical cancer research 13 (3), 832-838, 2007 | 150 | 2007 |
| Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion R Jagadeeswaran, H Surawska, S Krishnaswamy, V Janamanchi, ... Cancer research 68 (1), 132-142, 2008 | 145 | 2008 |
| A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways JY Chen, YA Tang, SM Huang, HF Juan, LW Wu, YC Sun, SC Wang, ... Cancer research 71 (2), 473-483, 2011 | 144 | 2011 |
| An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment CH Hsieh, HC Hsieh, FH Shih, PW Wang, LX Yang, DB Shieh, YC Wang Theranostics 11 (14), 7072, 2021 | 131 | 2021 |
| hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing CF Lee, DSC Ou, SB Lee, LH Chang, RK Lin, YS Li, AK Upadhyay, ... The Journal of clinical investigation 120 (8), 2920-2930, 2010 | 130 | 2010 |
| Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients RC Tseng, CC Lee, HS Hsu, C Tzao, YC Wang Neoplasia 11 (8), 763-W11, 2009 | 127 | 2009 |
| CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases YHC Tan, S Krishnaswamy, S Nandi, R Kanteti, S Vora, K Onel, R Hasina, ... PloS one 5 (1), e8972, 2010 | 119 | 2010 |
| Prognostic significance of p53 codon 72 polymorphism in lung carcinomas YC Wang, HS Lee, SK Chen, YY Chang, CY Chen European journal of cancer 35 (2), 226-230, 1999 | 116 | 1999 |
Yen-An TangCenter for Genomic Medicine, NCKUGeverifieerd e-mailadres voor msa.hinet.net
